Anupam Rasayan India Ltd
NSE:ANURAS
Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The company is involved in the custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and technologies for Indian and global customers. Its life science related specialty chemicals comprises of products related to agrochemicals, personal care, and pharmaceuticals. The company manufactures agro intermediates and agro active ingredients, such as insecticides, fungicides and herbicides and plant growth regulators. Its personal care includes anti-bacterial and ultraviolet protection intermediates and ingredients. Its pharmaceuticals include developing of intermediates and key starting materials for active pharmaceutical ingredients. Its other specialty chemicals include speciality pigments, speciality dyes, and polymer additives. The company has six manufacturing units are located in Sachin, Surat and Jhagadia, Bharuch in the state of Gujarat.
Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The company is involved in the custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and technologies for Indian and global customers. Its life science related specialty chemicals comprises of products related to agrochemicals, personal care, and pharmaceuticals. The company manufactures agro intermediates and agro active ingredients, such as insecticides, fungicides and herbicides and plant growth regulators. Its personal care includes anti-bacterial and ultraviolet protection intermediates and ingredients. Its pharmaceuticals include developing of intermediates and key starting materials for active pharmaceutical ingredients. Its other specialty chemicals include speciality pigments, speciality dyes, and polymer additives. The company has six manufacturing units are located in Sachin, Surat and Jhagadia, Bharuch in the state of Gujarat.
Strong Revenue Growth: Consolidated revenue for 9 months FY '26 rose 84% year-on-year to INR 1,730 crores, with Q3 revenue up 31% year-on-year at INR 512 crores.
Profitability Up: 9-month EBITDA grew 53% year-on-year to INR 402 crores, and PAT increased 71% to INR 166 crores; Q3 PAT was INR 61 crores, up 12%.
Business Diversification: Revenue was well spread across Agro, Pharma, Personal Care, and Performance Materials, with notable recovery in agro demand and strong growth in pharma and performance materials.
Major Acquisition: Anupam signed an agreement to acquire Jayhawk Fine Chemicals in the US, aiming to expand its North America footprint and enhance access to innovation-led end markets.
Export Strength: Exports made up 58% of total revenue, underlining a diversified global presence.
Working Capital Improvement: Working capital days have come down, with management targeting below 180 days by FY '27.
Jayhawk Impact: The Jayhawk acquisition is expected to be EPS accretive from day one, but was not reflected in the current results.
